ibh-symbol
IBH NEWS READ MORE
Back to Homepage
  • About Us
  • Resources
  • Providers
  • Members
IBH
MENU
  • Behavioral Health
    • Managed Behavioral Health
    • Substance Abuse Monitoring
    • Network Rental
    • Telehealth
  • Employer Solutions
    • Occupational Medicine
    • Workers Comp
    • Fitness for Duty
    • Professional Monitoring
    • Pre-Employment Screening
    • Medical Management & Accommodations
  • Population Health
    • Healthcare Delivery System
    • Member Engagement and Wellness
    • Patient Engagement
    • Maternity
    • Behavioral Health Screening Tools
    • Pain and Opioid Tools
  • EAP & Assistance Programs
    • Employee Assistance Program
    • Other Assistance Programs
    • Resilience Training
    • Tele-EAP
  • Research & Data
    • Data Streams
    • NAVIPPRO Research & Analytics
SEARCH GET IN TOUCH

Posters

MORE posts
Posters
Profiling non-medical use of tapentadol products among recreational drug abusers

Taryn Dailey-Govoni, Jared Beaumont, Theresa Cassidy Inflexxion, Inc., Waltham, MA, USA Presented at PAINWeek 2017 Read our poster for “Profiling non-medical use of tapentadol products among recreational drug abusers” here Abstract Purpose Prescription opioid misuse and abuse is a public health epidemic in the United States (ONDCP 2015) and a growing source of morbidity, mortality, […]

CONTINUE READING
Posters
Abuse and route of administration prevalence for tapentadol products within the NAVIPPRO® ASI-MV® surveillance system

Jared Beaumont, M.P.H.1, Theresa Cassidy, M.P.H.1, Taryn Dailey Govoni, M.P.H.1 Presented at International Conference on Opioids 2017 See our poster for “Abuse and route of administration prevalence for tapentadol products within the NAVIPPRO® ASI-MV® surveillance system” here Abstract Post-market surveillance data indicate low abuse levels of tapentadol products, but research regarding the route of administration […]

CONTINUE READING
Posters
A Cross-Sectional Analysis of Economic, Medical, and Legal Outcomes of Adults in Substance Abuse Treatment centers with Possible or Probable Schizophrenia

Kimberlee J. Trudeau, Joanna Burtner, Kruti Joshi, Albert Villapiano, Megan Jones, & Stephen F. Butler Presented at ARM 2016 See our poster for “A Cross-Sectional Analysis of Economic, Medical, and Legal Outcomes of Adults in Substance Abuse Treatment centers with Possible or Probable Schizophrenia” here Research Objective:  In the fragmented US healthcare system, patients seeking substance abuse […]

CONTINUE READING
Posters
Recent Study: Progression of non-medical use of hydrocodone combination products: results from an Internet survey of recreational drug users

Earlier this year, Inflexxion and KemPharm Pharmaceuticals presented a poster at the International Conference on Opioids based on a recent study of non-medical use of prescription opioids.  According to SAMSHA, Non-medical use of prescription opioids continues to increase.  However, little is known about the potential impact commonly prescribed opioids, such as hydrocodone combination products (HCPs), have […]

CONTINUE READING
Posters
Patterns of abuse of hydrocodone combination products: Results from an Internet survey of recreational drug users

Theresa A. Cassidy, MPH, Natasha K. Oyedele, MPH, Jared Beaumont, MPH, Stephen F. Butler, PhD Presented at PAINWeek 2015 See our poster for “Patterns of abuse of hydrocodone combination products: Results from an Internet survey of recreational drug users” here Summary: Researchers conducted this study to examine the progression of hydrocodone combination products (HCP) abuse, routes of administration, and […]

CONTINUE READING
Posters
The changing abuse ecology: implications for evaluating the abuse pattern of extended-release oxymorphone and abuse-deterrent opioid formulations

Theresa A. Cassidy, Jared Beaumont, Veronica Urdaneta, Simon H. Budman, Stephen F. Butler Presented at PAINWeek 2014 See our poster for “The changing abuse ecology: implications for evaluating the abuse pattern of extended-release oxymorphone and abuse-deterrent opioid formulations” here Abstract Purpose FDA Guidelines released in January 2013 on evaluating abuse-deterrent formulations (ADFs) recommend direct comparison […]

CONTINUE READING
Posters
Comparing abuse of extended-release versus immediate-release opioid analgesics adjusted for number of prescriptions and morphine-equivalent dose

Stephen F. Butler, PhD, Theresa A. Cassidy, MPH, Taryn Dailey,  BA1, & Paul M. Coplan, ScD2, Presented at CPDD 2014 See our poster for “Comparing abuse of extended-release versus immediate-release opioid analgesics adjusted for number of prescriptions and morphine-equivalent dose” here Abstract Aims: It has been suggested that abuse risk of extended-release (ER) opioids is […]

CONTINUE READING
Posters
Evaluation of an ADF product’s route of administration profile

Theresa A. Cassidy, MPH, Simon H. Budman, PhD, Stephen F. Butler, PhD Presented at CPDD 2014 See our poster for “Evaluation of an ADF product’s route of administration profile” here Abstract Aims: Assessing the impact on abuse patterns of the introduction of abuse deterrent opioid formulations (ADFs) has focused, in part, on comparisons of the […]

CONTINUE READING
Posters
Abuse of Reformulated OPANA® ER: early findings from NAVIPPRO® data

Theresa A. Cassidy, MPH, Emily C. McNaughton, MPH , Kimberly Lobo, MPH , Simon H. Budman, PhD, Stephen F. Butler, PhD Presented at American Society of Addiction Medicine (ASAM), Chicago, IL, April 25-27th, 2013  See our poster for “Abuse of Reformulated OPANA® ER: early findings from NAVIPPRO® data” here Abstract Summary: Reformulated extended release (ER) oxymorphone (OPANA […]

CONTINUE READING
Posters
Change in prescription opioid abuse after introduction of an abuse deterrent formulation

Theresa A. Cassidy, MPH, Emily C. McNaughton, MPH , Stephen F. Butler, PhD, Simon H. Budman, PhD Presented at PAINWeek 2012 See our poster for “Change in prescription opioid abuse after introduction of an abuse deterrent formulation” here Abstract OBJECTIVE: The reformulation of oxycodone hydrochloride controlled-release (CR) tablets in August 2010 created a natural experiment […]

CONTINUE READING
Posters
Differences in rates of abuse and routes of administration for original and reformulated extended-release oxycodone among individuals assessed for substance abuse

S.F. Butler, H. Chilcoat, T.A. Cassidy, R.A. Black, C. Landau, S.H. Budman, P. Coplan Presented at IASP Milan 2012 See our poster for “Differences in rates of abuse and routes of administration for original and reformulated extended-release oxycodone among individuals assessed for substance abuse” here Abstract Oxycodone hydrochloride controlled-release, also known as extended-release oxycodone (ER oxycodone), […]

CONTINUE READING
Posters
Effects of reformulated OxyContin® among patients assessed for substance abuse treatment in the NAVIPPRO sentinel surveillance network

Ryan Black, Paul Coplan, Theresa A. Cassidy, Howard Chilcoat, Simon H. Budman, Craig Landau, Stephen F. Butler Presented at APS Public Health 2012 See our poster for “Effects of reformulated OxyContin® among patients assessed for substance abuse treatment in the NAVIPPRO sentinel surveillance network” here Abstract Reformulated OxyContin® (oxycodone HCl controlled-release) Tablets (ORF) have physiochemical […]

CONTINUE READING
Load More

We drive value on your investment for your business.

REQUEST A SALES CONSULTATION

Solutions

  • Behavioral Health
  • EAP & Assistance Programs
  • Employer Solutions
  • Managed Behavioral Health
  • Member Engagement and Wellness

Services

  • Pain and Opioid Tools
  • Patient Engagement
  • Population Health
  • Research & Data
  • Resilience Training

About

  • Executives
  • Education
  • Blog
  • Careers
  • Contact Us
Privacy Policy © 2021 IBH. All rights reserved.

Recent News

IBH Acquisition of HMC HealthWorks Raises Bar for Population Health

Feb 09, 2021

IBH Population Health Solutions Completes Acquisition of HMC HealthWorks

Dec 22, 2020

IBH Announces Breakthrough Programs for Panic Attacks and PTSD in Partnership with Freespira

Dec 15, 2020

IBH Announces Industry First Program for Parenting and Childcare to Help Families Better Navigate Through Current Challenges with Work Transition and Onsite/Online Schooling

Sep 24, 2020
VIEW ALL NEWS
CLICK TO CLOSE
IBH NEWS